T CELL MANUFACTURING COMPOSTIONS AND METHODS
The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Europäisches Patentamt - (2022) vom: 09. Juni Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
VAN BUUREN MARIT M [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-06-09, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-26 |
---|
Patentnummer: |
US2022177840 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA001728342 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA001728342 | ||
003 | DE-627 | ||
005 | 20240426160617.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA001728342 | ||
035 | |a (EPA)US2022177840 | ||
035 | |a (EPA)66438061 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a VAN BUUREN MARIT M |e verfasserin |4 aut | |
245 | 1 | 0 | |a T CELL MANUFACTURING COMPOSTIONS AND METHODS |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2022-06-09, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-26 | ||
520 | |a The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy. | ||
650 | 4 | |a bio | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a LENKALA DIVYA REDDY |e verfasserin |4 aut | |
700 | 0 | |a VAN DEN BURG JOOST HUIBERT |e verfasserin |4 aut | |
700 | 0 | |a KOHLER JESSICA |e verfasserin |4 aut | |
700 | 0 | |a GOLDSTEIN MATTHEW |e verfasserin |4 aut | |
700 | 0 | |a FRITSCH ED |e verfasserin |4 aut | |
700 | 0 | |a DE BOER RENATE |e verfasserin |4 aut | |
700 | 0 | |a SCHUMACHER TON |e verfasserin |4 aut | |
700 | 0 | |a BAKKER NOOR |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 09. Juni |
773 | 1 | 8 | |g year:2022 |g day:09 |g month:06 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/66438061/publication/US2022177840A1?q=US2022177840 |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2022 |b 09 |c 06 |